©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 21, 2014; 20(15): 4141-4150
Published online Apr 21, 2014. doi: 10.3748/wjg.v20.i15.4141
Published online Apr 21, 2014. doi: 10.3748/wjg.v20.i15.4141
Table 1 Comparison of classifications
| Okuda staging system[13] | |||||||
| Score | |||||||
| 0 | 1 | ||||||
| Tumor size | ≤ 50% of the liver | > 50% of the liver | |||||
| Albumin (g/dL) | ≥ 3 | < 3 | |||||
| Bilirubin (mg/dL) | < 3 | ≥ 3 | |||||
| Ascites | Absent | Present | |||||
| CLIP score[14] | |||||||
| Score | |||||||
| 0 | 1 | 2 | |||||
| Tumour morphology | Uninodular and extension ≤ 50% | Multinodular and extension ≤ 50% | Massive or extension > 50% | ||||
| Child–Pugh score | A | B | C | ||||
| Alpha-fetoprotein (ng ⁄ mL) | < 400 | ≥ 400 | - | ||||
| Portal vein thrombosis | Absent | Present | - | ||||
| GRETCH score[21] | |||||||
| Score | |||||||
| 0 | 1 | 2 | 3 | ||||
| Karnofsky index | ≥ 80% | < 80% | |||||
| Bilirubin (μmol ⁄ L) | < 50 | ≥ 50 | |||||
| Alkaline phosphatase | < 2 X ULN | ≥ 2 X ULN | |||||
| Alpha-fetoprotein (μg⁄L) | < 35 | ≥ 35 | |||||
| Portal vein thrombosis | Absent | Present | |||||
| BCLC[16] | |||||||
| Stage | |||||||
| 0 (very early) | A (early) | B (intermediate) | C (advanced) | D (end stage) | |||
| ECOG Performance Status | 0 | 0 | 0 | 1-2 | 3-4 | ||
| Liver function | Child-Pugh A-B | Child-Pugh A-B | Child-Pugh A-B | Child-Pugh A-B | Child-Pugh C | ||
| Tumor stage | Single | Single or 3 nodules < 3 cm | Multinodular | Vascular invasion or extrahepatic spread | Any | ||
| CUPI[23] | |||||||
| VARIABLE | Weight | ||||||
| TNM stage | I and II | -3 | |||||
| III | -1 | ||||||
| IV | 0 | ||||||
| Total Bilirubin (μmol ⁄ L) | < 34 | 0 | |||||
| 34-51 | 3 | ||||||
| ≥ 52 | 4 | ||||||
| Ascites | 3 | ||||||
| Alpha-fetoprotein > 500 ng/mL | 2 | ||||||
| Alkaline phosphatase > 200 IU/L | 3 | ||||||
| Asymptomatic disease on presentation | -4 | ||||||
| JIS[24] | |||||||
| Score | |||||||
| 0 | 1 | 2 | 3 | ||||
| Child-Pugh score | A | B | C | ||||
| TNM stage by LCSGJ | I | II | III | IV | |||
| Tokyo[22] | |||||||
| Score | |||||||
| 0 | 1 | 2 | |||||
| Albumin (g/dL) | > 3.5 | 2.8-3.5 | < 2.8 | ||||
| Bilirubin (mg/dL) | < 1 | 1-2 | > 2 | ||||
| Tumor size (cm) | < 2 | 2-5 | > 5 | ||||
| Numbers of nodules | ≤ 3 | - | > 3 | ||||
| AJCC/UICC TNM staging system 7th ed[12] | |||||||
| Group | Description | Stage grouping | |||||
| T1 | Single tumor without vascular invasion | STAGE I | T1 | N0 | M0 | ||
| T2 | Single tumor with vascular invasion or multiple tumors, none > 5 cm | STAGE II | T2 | N0 | M0 | ||
| T3a | Multiple tumors, any > 5 cm | STAGE IIIA | T3a | N0 | M0 | ||
| T3b | Single tumor or multiple tumors of any size involving a major branch of portal or hepatic vein(s) | STAGE IIIB | T3b | N0 | M0 | ||
| T4 | Tumors with direct invasion of adjacent organs other than the gallbladder, or perforation of visceral peritoneum | STAGE IIIC | T4 | N0 | M0 | ||
| N1 | Regional lymph node metastasis | STAGE IVA | Any T | N1 | M0 | ||
| M1 | Distant metastasis | STAGE IVB | Any T | Any N | M1 | ||
- Citation: Maida M, Orlando E, Cammà C, Cabibbo G. Staging systems of hepatocellular carcinoma: A review of literature. World J Gastroenterol 2014; 20(15): 4141-4150
- URL: https://www.wjgnet.com/1007-9327/full/v20/i15/4141.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i15.4141